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Abstract
Oxidative stress (OS) has been implicated in a variety of pathological conditions,
including diabetes mellitus, characterized by hyperglycemia. In the present study, OS
induced by hyperglycemia and the effect of trolox, a vitamin E analog, were studied in
cardiomyocytes and H9c2 cells exposed to 15 to 33mM glucose (HG) for 24 to
72 hours in Dulbecco modified Eagle medium. Cells treated wirh 24 or 33mM glucose
for 24 hours or above showed decreased viability and adenosine triphosphate (ATP)
content with a concomitant increase in radicals of oxygen species, calcium (Ca2+),
mitochondrial permeability transition, and oxidative markers, confirming that the
cells were under stress. However, upon exposure to 15mM glucose for 24 hours,
H9c2 cells maintained homeostasis and ATP generation. Pretreatment of cells with
trolox reduced HG‐induced OS to control levels. Here, we report that the toxic effect
of HG is highly regulated and that OS induction can be prevented with Trolox, a
potential inhibitor of membrane damage.
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1 | INTRODUCTION
Hyperglycemia has been studied to inflict cell injury in several cells, and
chronic hyperglycemia causes diabetes and diabetes‐related complica-
tions.[1] Although high glucose exposure causes persistent alterations in
macromolecules,[2] brief exposure to hyperglycemia induces acute
changes in cellular metabolism. High glucose mediates cardiovascular
complications, and oxidative stress (OS) is implicated in the pathogenesis
of diabetic patients.[3,4] OS has been defined as an imbalance between
pro‐oxidants and antioxidants, resulting in excess production of radicals
of oxygen species (ROS). Experimental evidence indicated ROS as the
causative agent for tissue damage associated with diabetes.[5,6] Different
metabolic pathways have been proposed, including enhanced mitochon-
drial electron‐transport chain, for hyperglycemia‐induced ROS accumula-
tion.[7–9] High levels of intracellular glucose‐derived pyruvate facilitate an
increase in the flux of NADH and FADH2 into the electron‐transport
chain, thereby causing depolarization of mitochondrial membrane
potential (Δѱm). Cardiac tissue is known for the abundant presence of
mitochondria and is known to provide continuous energy for cardiac
function.[10] As a result, diabetic individuals often show an impairment
of mitochondrial membrane function with a reduction in adenosine
triphosphate (ATP) synthesis before the onset of glucose intoler-
ance.[11] This metabolic disorder also lessens the cardiac mitochondrial
bioenergetics, resulting in decreased contractile function in diabetic
hearts.[12,13]
Hyperglycemia‐induced ROS causes opening of the mitochon-
drial permeability transition (MPT) pore, thereby causing changes in
Δѱm and eventually releasing a number of apoptotic factors from the
mitochondria.[14] Furthermore, earlier studies have indicated that the
impairment of mitochondrial function is partially due to decreased
mitochondrial transcription factor A activity or expression.[15,16] Apart
from excessive ROS accumulation influenced by hyperglycemia, high
glucose also causes an overload of Calcium (Ca2+),[17,18] and this
abnormality in Ca2+ handling significantly reduced contractile function
in diabetic hearts. Also, the intracellular retention of Ca2+ is markedly
associated with this metabolic disorder.[19] As a consequence, Ca2+
channel blockers in conjunction with antioxidants have been proved to
be effective in the cardiac performance in the diabetic state.[20]
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Maladaptive signaling pathways induced by increased ROS may
contribute to the pathogenesis of diabetic cardiomyopathy[21]; however,
the pathophysiological relevance of increased myocardial ROS produc-
tion in diabetes‐related complications needs to be characterized. Since
OS results in the reduction of myocardial antioxidants, the loss of Δѱm
and increased superoxide,[22] it is of interest to precisely assess the role
of antioxidants that can minimize potential oxidative damage. Vitamin E
is considered to be a universal participant of the antioxidant defense
mechanism. Among the vitamin E analogs that are used, Trolox seems to
have an advantage over others because of its moderate water solubility
and the fact that it can be added directly to an intact system.[23]
Cardiovascular cell injury is one of the complications of diabetes.
The present study aims to gain insights into hyperglycemia‐induced
cell mortality. We examined the crosstalk among ROS, Ca2+, and
MPT, which are reflected by high glucose concentrations and the
duration of exposure. A strategy that focuses on decreasing OS as
well as enhancing mitochondrial function may provide an important
option to overcome diabetic complications. To this end, we tested
Trolox, a water‐soluble vitamin E analog, for its antioxidant property
and protection against mitochondrial damage. Here, we investigated
hyperglycaemic (HG) episodes at different concentrations and
exposure periods in an in vitro model to define the probable critical
situation where glucose can be toxic to cardiac cells.
2 | MATERIALS AND METHODS
2.1 | Chemicals
ATP determination kit, Fluo‐4‐AM cell permeant, H2DCFDA, and
Mitotracker orange were obtained from Molecular probes, (Invitrogen,
Carlsbad, CA). D‐glucose, dimethyl sulfoxide (DMSO), dinitro phenyl
hydrazine (DNPH), Dulbecco modified Eagle medium (DMEM) cell
culture media, fetal bovine serum (FBS), mannitol, penicillin, sodium
dodecyl sulfate (SDS), streptomycin, thiazolyl blue tetrazolium bromide
(MTT), thiobarbituric acid (TBA), trichloro acetic acid (TCA), 1,1,3,
3‐tetra methoxy propane (TMP), and 6‐hydroxy‐2,5,7,8‐tetramethyl
chromane‐2‐carboxylic acid (trolox) were obtained from Sigma‐Aldrich,
(St. Louis, MI). Common chemicals were of reagent grade.
2.2 | Cell culture and treatment
Rat cardiomyocyte (H9c2) cell lines were obtained from the National
Centre for Cell Science, Pune, India. Cells were cultured in DMEM
with 10% FBS, and 1% antibiotics (100 U/mL penicillin, 100 µg/mL
streptomycin), 5% CO2, at a temperature of 37°C with 95% humidity.
When 60% to 70% cell confluence was reached, hyperglycemia
was induced by adding 15, 24, and 33mM of D‐glucose to the media.
To evaluate the protective role of trolox, cells cultured in similar
concentrations were treated with 100 µmol of trolox for 24 hours
before hyperglycaemic (HG) treatment (pretreatment). Trolox‐trea-
ted HG cells and HG cells in the aforementioned concentrations
along with control cells (HG‐C), and the trolox‐treated control were
maintained for 24, 48, and 72 hours.
2.3 | Cell viability assay
The viability of the cells was assessed by MTT (3‐(4, 5‐dimethylthia-
zol‐2‐thiazolyl)‐2,5‐diphenyl‐2‐4‐tetrazolium bromide) following the
method described by Hansen et al.[24] Briefly, 3 × 103 cells were
seeded in 96‐wells plate and incubated overnight at 37°C with 5%
CO2. After reaching confluence and the subsequent treatments, the
cells were washed with phosphate buffer (PBS). MTT (2 mg/mL) was
added to each well, and cells were incubated for 4 hours at 37°C.
Formazan crystals were dissolved with DMSO, and optical density
was measured at 570 nm, using a multimode plate reader (Infinite
200 PRO, Tecan, Männedorf, Switzerland).
To confirm that the change in cell viability due to high glucose
was not a consequence of high osmolarity, H9c2 cells were incubated
with 15, 24, and 33mM mannitol for 24, 48, and 72 hours. The cells
were assessed for viability as mentioned above.
2.4 | Measurement of cellular ROS generation
Total ROS in H9c2 cells were measured by exposing them to the
aforementioned HG conditions for 24, 48, and 72 hours, with and
without trolox pretreatment. Briefly, after treatment, the cells were
washed in PBS and incubated for 15minutes in 20 μM H2DCFDA.
The cells were then washed, and fluorescence intensity was
measured using a fluorescent microscope (Olympus IX, Olympus,
Tokyo, Japan) under Ex/Em–495/527 nm and quantified using Image
Pro Express version 6.3 software (Olympus, Tokyo, Japan).
2.5 | ATP measurement
Cells were plated in 96‐well plates, and ATP content was determined
using luciferin and luciferase with the ATP determination kit, as described
by the manufacturers. Luminescence was read by using a multimode
plate reader (Infinite 200 PRO, Tecan, Männedorf, Switzerland).
2.6 | Assessment of MPT
To measure the changes in mitochondrial (mt.) permeability transi-
tion due to HG conditions, H9c2 cells were stained with a fluorescent
mitochondrion‐selective probe mitotracker orange. Under a fluor-
escent microscope (Olympus IX, Japan) using a green excitation filter
(Ex/Em 554/576 nm), the fluorescent intensity was measured and
quantified by Image Pro Express version 6.3 software (Olympus IX,
Olympus, Tokyo, Japan). Briefly, the cells were exposed to HG
concentrations for 24, 48, and 72 hours. Trolox‐treated and
untreated cells were washed in PBS and incubated for 20min in
mitotracker orange. After incubation, the cells were washed in PBS
and subjected to fluorescence recordings.
2.7 | Measurement of cellular Calcium
The intracellular Ca2+ concentrations in cultured H9c2 cells were
measured using the Fluo‐4/AM dye under Ex/Em 491/516 nm in a
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fluorescent microscope (Olympus IX, Japan). Cells were given HG
treatments with and without trolox pretreatment for 24, 48, and
72 hours. After treatment, the cells were washed in PBS and were
incubated in 5 µM Fluo‐4/AM containing 5mM CaCl2 in PBS for
20minutes at 37°C and were resuspended in PBS. Cell fluorescence
was quantified using the Image Pro Express version 6.3 software
(Olympus).
2.8 | Lipid peroxidation in H9c2 cells
Malondialdehyde (MDA) generation was spectrophotometrically as-
sayed to understand the extent of lipid peroxidation by the method of
Okhawa et al.[25] Briefly, cell homogenates containing 8% SDS were
vortexed and incubated for 10minutes at room temperature. Then, 20%
acetic acid and 0.6% TBA were added, and the cells were incubated for
50minutes in a boiling water bath. After cooling, a butanol and pyridine
(15:1) mixture was added to the cocktail, which was then vortexed. The
thoroughly mixed cocktail was centrifuged for 5minutes. The organic
layer was separated, and absorbance was read at 532 nm against a
blank. TMP was used as a standard, and the extent of lipid peroxidation
was expressed as nmol of MDA/mg protein.
2.9 | Protein carbonylation in H9c2 cells
Protein carbonylation was assayed as a marker of protein oxidation
spectrophotometrically by the method of Levine et al.[26] Briefly, cell
homogenate was centrifuged for 10minutes at 4°C. The collected
supernatant was equally divided into DNPH‐treated and untreated
fractions, which were incubated for 1 hour at room temperature.
TCA (equal volume) was added to both fractions and recentrifuged at
4°C for 10minutes. The supernatant was discarded, and the
precipitate was washed in an ethyl acetate and ethanol mixture
(1:1), dissolved in 6M guanidine hydrochloride, and centrifuged for
10minutes at 4°C. The supernatant was collected, and absorbance
was read at 365 nm against respective DNPH untreated fractions for
each replicate. The molar extinction coefficient 2.2 × 104M−1 cm−1
was used to obtain the extent of protein carbonyl incorporation and
expressed as nmol DNPH incorporated/mg protein.
2.10 | Statistical analyses
Data are presented as the mean ± standard error of the mean.
Statistical analysis was performed using Prism 6.01 software
(GraphPad Inc., La Jolla, CA) and SPSS statistics 20 (IBM, Armonk,
NY). Data were initially tested for homogeneity (Leven's test) to
determine the suitable analysis. Two‐way analysis of variance
followed by Tukey's post hoc tests with a single pooled variance
was used to assess the differences in means between different HG
concentrations and trolox treatment. Two‐tailed Pearson's corre-
lation was used to determine the degree of relativity between
ROS, OS markers, mitochondrial structural, and functional integ-
rity with cell viability in H9c2 cells. Probability values P < 0.05
were selected as the point of minimum significance.
3 | RESULTS
3.1 | Viability of H9c2 cells subjected to high
glucose
The viability of cardiomyocytes under high glucose stress was
assessed by MTT test. Incubation in high glucose for 24 hours
induced a significant decrease in the viability of H9c2 cells, by 20% at
the highest concentration 33mM (P < 0.001), but not at lower
concentrations (P > 0.05) (Figure 1A). A concentration‐dependent
decrease in viability to higher glucose was significantly evident in
H9c2 cells incubated for a longer period of 48 hours. Cell viability
was reduced by 13% (P < 0.05), 16% (P < 0.01), and 26% (P < 0.001)
after incubation with 15, 22, and 33mM glucose, respectively
(Figure 1B), while at 72 hours, similar concentrations induced a
decrease in viability of 18% (P < 0.01), 27% (P < 0.0001), and 48%
(P < 0.0001), respectively. However, the cells that were exposed to
mannitol, an osmotic control, did not cause significant changes in
viability (Supporting Information Figure S1), suggesting that the high
glucose–induced decrease in viability was not a consequence of high
osmolarity. Further, prior exposure to the vitamin E analog trolox
obliterated the decrease in viability caused by high glucose
treatment. The role of trolox in H9c2 cell survival in HG conditions
is very evident at 72 hours, with the increased viability of 28%
(P < 0.0001), 24% (P < 0.01), and 64% (P < 0.0001) after treatment
with 15, 24, and 33mM glucose, respectively (Figure 1C).
3.2 | High glucose–induced ROS
The intracellular ROS levels were measured in terms of O2
•‒. After
the treatment of cells with various concentrations of glucose, an
increase in the production of free radicals was seen in both dose‐ and
time‐dependent manners (Figure 2A, 2C, and 2E). Figure 2B shows
that HG significantly increased the level of O2
•‒ by 9% (P < 0.0001)
and 15% (P < 0.0001) at 24mM and 33mM glucose, respectively,
after incubation for 24 hours. A similar trend in ROS was also
observed in cells exposed to HG for 48 hours with an increase of 23%
(P < 0.0001) and 60% (P < 0.0001) at 24 and 33mM, respectively, and
the maximal effect was recorded at 72 hours with an ROS increase of
63% and 138% (P < 0.0001) for the two higher glucose concentra-
tions (Figure 2D). An increase in O2
•‒ upon exposure to HG was
attenuated by Trolox at 5mM under all experimental conditions. The
rise in ROS levels at 24 and 33mM HG was reversed by 15% and
27% (P < 0.0001) at 48 hours, respectively, and 30% and 33%
(P < 0.0001) at 72 hours (Figure 2F), respectively. HG conditions
induced by 15mM HG failed to evoke the generation of O2
•‒,
irrespective of the duration of treatment.
3.3 | High glucose–induced mitochondrial
dysfunction by decreasing ATP
Exposure to various concentrations of HG for 24 hours had no impact
on the ATP content in cardiac cells (Figure 3A). However, exposure
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for 48 hours in 15, 24, and 33mM HG decreased the ATP content by
20% (P < 0.01), 40% and 55%, respectively (P < 0.0001). Trolox
pretreatment resulted in elevated ATP levels by 30% (P < 0.0001)
in 15mM and 45% (P < 0.0001) in 24 and 33mM glucose (Figure 3B).
Also, 72 hours of exposure to HG resulted in a significant depletion
of ATP levels. The ATP level decreased by 17% (P < 0.05) in 15mM
HG and 53% in 24 and 33mM (P < 0.0001) HG. Interestingly, an
ameliorative effect of trolox was revealed by post hoc tests, as there
was a significant increase in ATP levels by 21% in 15mM (P < 0.01)
and 50% in 24 and 33mM (P < 0.0001) (Figure 3C). The decreased
ATP concentration compared with the decreased viability of the cell
population suggests the possibility of extended incubation to HG
inducing mitochondrial dysfunction.
3.4 | Changes in MPT in HG treatments
Mitochondrial ATP synthesis is dependent on the proton‐motive
force, in which ΔѱM has a major role. Since prolonged exposure to
HG caused decreased ATP concentrations in H9c2, we examined the
MPT using mitotracker orange dye. After 24 hours of exposure to HG
at 15, 24, and 33mM concentrations, an increase in MPT by 11%
(P < 0.01), 23% and 28% (P < 0.0001), respectively, was evoked. This
observed increase in MPT after 24 hours of HG stress was reversed
by pretreatment with trolox. A significant reduction of 13% and 16%
(P < 0.0001) was evident in 24 and 33mM glucose, respectively
(Figure 3D and 3E). HG exposure for 48 hours caused an increase in
permeability by 40%, 56%, and 75% (P < 0.0001) with 15, 24, and
33mM HG, respectively. Trolox pretreatment restored the mem-
brane permeability as a reduction in cell fluorescence by 27%, 35%,
and 45% (P < 0.0001) in HG concentrations (Figure 3F and 3G). MPT
significantly increased in the three concentrations of high glucose by
almost 80% to 90% (P < 0.0001) and trolox pretreatment successfully
restored the MPT by 48% (P < 0.0001) (Figure 3H and 3I).
3.5 | High glucose–induced intracellular calcium
elevation
Intracellular calcium (Ca2+)i is closely related to ROS accumulation.
Thus, ROS increase is likely to influence Ca2+ regulation. The exposure
of H9c2 cells to high glucose caused a concentration‐ and time‐
dependent increase in (Ca2+)i. The exposure of cells to HG for 24 hours
resulted in a significant increase in the fluorescent intensity of the Fluo‐
4 in cells at 33mM by 8% (P < 0.01). However, pretreatment with trolox
before HG exposure blunted the hyperglycemia‐induced intracellular
calcium increase in cardiomyocytes by 6% (P <0.001) (Figure 4A and
4B). At 48 hours of HG exposure, a concentration‐dependent increase in
Ca2+ by 14% and 37% (P <0.0001) was evident in 24 and 33mM
glucose, respectively. An ameliorative effect of trolox became evident in
cells pretreated with trolox and a decrease in Ca2+ levels of 11%
(P < 0.001) and 22% (P < 0.0001) was found in 24 and 33mM,
F IGURE 1 Variation in cell viability at 24 hours (A), 48 hours
(B), 72 hours (C) in hyperglycemic and trolox‐treated H9c2 cells.
Values are mean ± SEM (octaplicate). Two‐way ANOVA with
Tukey's multiple comparison test was used and significance in
mean difference was represented as ****P < 0.0001; **P < 0.01
with respective hyperglycemic subgroup, ####P < 0.0001;
###P < 0.001; ##P < 0.01; #P < 0.05 with control. ANOVA, analysis
of variance; SEM, standard error of the mean
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respectively (Figure 4C and 4D). In addition, 72 hours exposure to 15,
24, and 33mM HG caused a significant increase in Ca2+ by 14%
(P <0.05), 26% and 47%, respectively (P < 0.0001). Trolox effectively
reduced intracellular Ca2+ by 10% (P < 0.05), 15% (P <0.001) and 23%
(P <0.0001) in high glucose concentrations (Figure 4E and 4F).
3.6 | MDA and protein carbonyl content levels as
biomarkers of OS induced by high glucose
The determination of the MDA level is a marker of lipid oxidation,
while carbonyl levels are used as an index of the extent of oxidative
damage to proteins during stress induced by HG exposure. High
glucose caused concentration‐ and duration‐dependent increases in
the mean MDA level (nmol/mL) of H9c2 cells. Tukey's post hoc test
revealed a 2‐ to 2.3‐fold (P < 0.0001) increase in lipid peroxidation
(LPO) in 24 and 33mM HG, whereas trolox pretreatment caused a
reduction in LPO levels by 18% (P < 0.01) during 24‐hour HG exposure
(Figure 5A). A concentration‐dependent increase in LPO levels of 90%
(P < 0.001), 185%, and 220% (P < 0.0001) was seen after 48 hours of
HG exposure, whereas trolox exposure reduced LPO by 28%
(P < 0.001) (Figure 5B). Similarly, 72 hours of HG stress caused an
increase in LPO by 52% (P < 0.01), 170% (P < 0.0001), and 221%
(P < 0.0001) at 15, 24, and 33mM HG, respectively, and trolox
reduced LPO levels by 24% (P < 0.05) in 33mM HG (Figure 5C).
F IGURE 2 Total ROS in H9c2 cells microphotographs of 24, 48, and 72 hours post treatment are presented in panel A, C, and E. Values are
mean ± SEM (triplicate) represented in panel B, D, and F, respectively, as fluorescence intensity in A.U. Two‐way ANOVA with Tukey's multiple
comparison test was used and significance in mean difference was represented as ****P < 0.0001 with respective hyperglycemic subgroup,
####P < 0.0001 with control. Scale 10 µm ×40. ANOVA, analysis of variance; ROS, radicals of oxygen species; SEM, standard error of the mean
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F IGURE 3 Mitochondrial integrity in H9c2 cells ATP levels are represented as mean ± SEM (octaplicate) at 24 hours (A), 48 hours (B),
72 hours (C) after HG stress and trolox pretreatment. Microphotographs of mitochondrial permeability transition after treatment at 24 hrs,
48 hrs, and 72 hrs are presented in panels D, F, and H and fluorescence intensity in A.U. is represented in panel E, G, and I as mean ± SEM
(pentaplicate) respectively. Two‐way ANOVA with Tukey's multiple comparison test was used and significance in mean difference was
represented as ****P < 0.0001; **P < 0.01; *P < 0.05 with respective hyperglycemic subgroup, ####P < 0.0001; ##P < 0.01; #P < 0.05 with control.
Scale 10 µm ×40. ANOVA, analysis of variance; ATP, adenosine triphosphate; HG, hyperglycaemic; SEM, standard error of the mean
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The protein carbonyl content (PCC) of H9c2 was significantly higher
with high glucose treatment in a dose‐ and duration‐dependent manner
(Figure 5D‐F). The profound effect of HG seen in cells as PCC was more
evident for 48‐ and 72‐hour–stressed cells (P < 0.0001). Trolox, a water
soluble derivative of vitamin E that partitions well into the lipid layer
significantly reduced the high glucose–induced oxidation of membrane
lipids and proteins.
A two‐tailed Pearson correlation analysis revealed that a high
degree of negative correlation existed between cell survivability with
ROS generation (r = −0.84), MPT (r = −0.81), (Ca2+)i levels (r = −0.88),
MDA (r = −0.83), and PCC (r = −0.84). A similarl negative correlation
existed between ATP levels with ROS (r = −0.82), MPT (r = −0.87),
(Ca2+)i (r = −0.92), MDA (r = −0.83), and PCC (r = −0.69). A further
positive correlation was observed between ATP level and cell
survivability (r = 0.78) and between ROS with MPT (r = 0.73), (Ca2+)i
(r = 0.91), MDA (r = 0.88), PCC (r = 0.79). Such a positive correlation
was found between MPT with (Ca2+)i (r = 0.87), MDA (r = 0.71), PCC
(r = 0.58) and also between (Ca2+)i with MDA (r = 0.85), PCC
(r = 0.78), between MDA and PCC (r = 0.91). The above analysis
strengthen our hypothesis that HG stress–associated cell death in
H9c2 cells is due to increase in OS and the associated mitochondrial
dysfunction (Table 1).
F IGURE 4 Intracellular Ca2+ in H9c2 cell microphotographs of 24, 48, and 72 hours after treatment are presented in panels A, C, E. Values
are mean ± SEM (triplicate) represented in panels B, D, F, respectively. The fluorescence intensity is presented in A.U. Two‐way ANOVA with
Tukey's multiple comparison test was used, and significance in mean difference was represented as ****P < 0.0001; ***P < 0.001; **P < 0.01;
*P < 0.05 with respective hyperglycemic subgroup, ####P < 0.0001; ##P < 0.01; #P < 0.05 with control. Scale 10 µm ×40. ANOVA, analysis of
variance; SEM, standard error of the mean
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F IGURE 5 Extent of lipid peroxidation and protein carbonylation at 24 hours (A,D), 48 hours (B,E), 72 hours (C,F), respectively, in
hyperglycemic‐ and trolox‐treated H9c2 cells. Values are mean ± SEM (quadriplicate). Two‐way ANOVA with Tukey's multiple comparison test
was used, and significance in mean difference was represented as ****P < 0.0001; ***P < 0.001; **P < 0.01; *P < 0.05 with respective
hyperglycemic subgroup, ####P < 0.0001; ###P < 0.001; ##P < 0.01 with control. ANOVA, analysis of variance; SEM, standard error of the mean
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4 | DISCUSSION
The current study evaluates the relationship between hyperglycemia
and OS in H9c2 cells exposed to different HG concentrations and
time durations. Our results showed a significant decrease in cell
viability induced by 33mM glucose for 72 hours and are consistent
with earlier findings.[9,27] Exposure to various concentrations of
mannitol failed to increase mortality, indicating that cell death is due
to HG per se.[28,29]A majority of cells in HG incubations, except for
15mM, exhibited increased ROS levels, which resulted in approxi-
mately 15% mortality, indicating that increased ROS was not directly
translated into cell death. Apparently, the ROS levels at a certain
threshold induce changes in the redox state, leading to OS. Apart
from mitochondrial, additional sources of ROS production are gaining
importance in hyperglycemia‐induced cardiomyopathy.[30–32]
Mitochondria are the redox‐active compartments generating ATP
mostly through oxidative phosphorylation. In this study, the
intracellular ATP levels remained the same after 24‐hour HG
exposure; however, the ATP levels were significantly lowered in all
HG concentrations at 48 and 72 hours. We presume that ATP levels
are maintained for 24 hours at low glucose concentrations due to
altered electron flux, but that these are not sufficient to normalize
the proton gradient across the mitochondrial membrane.
Mitochondrial dysfunction is an important manifestation of ROS
generation induced by hyperglycemia. High ROS and low ATP
induce MPT, which in turn dissipates the Δѱm by providing protons
with an alternate route to the matrix.[33–35] Although glucose at
15 mM failed to evoke a response in Δѱm at 24 hours, a steady
increase in dye intensity was evident at later durations and at
higher concentrations. Apparently, the decreased mitochondrial
hyperpolarisation, along with the increased ROS and decreased ATP
levels and a reversal of these changes by trolox clearly, indicated
that hyperglycemia induced OS in cardiomyocytes. Our results are
in agreement with earlier studies on the hearts of STZ‐induced
diabetic mice and H9c2 cells treated with 33 mM glucose, which
showed that the mitochondrial pathway mediated cell loss and
restoration of Δѱm through taxifolin.[36]
Interactions between ROS and calcium signaling can be bidirec-
tional. In our study, alterations in (Ca2+)i followed the same pattern
as seen in ROS generation under the same experimental conditions,
indicating a probable crosstalk between the two messengers
(Table 1). Trolox prevented hyperglycemia‐induced Ca2+ levels. The
end products of free radicals serve as indicators of OS, which cause
macromolecular damage and contribute to the pathogenesis of
diabetes.[37,38] Concentration‐ and duration‐dependent HG‐induced
changes in PCC and MDA levels and reversal by trolox in H9c2 cells
further confirmed that hyperglycemia induced toxicity. Although the
transfer of Trolox into the cell is possibly hampered by its partial
hydrophilic nature, the residual trolox that might be retained in the
membrane would have lessened the PCC and MDA in high glucose‐
treated cells. Although numerous cell lines and animals were used in
the hyperglycemia‐induced OS as an important feature in diabetic
cardiomyopathy, its relevance to adult human cardiomyocytes was
less contemplated upon. In the present study, we used H9c2 cells,
which are undifferentiated myoblasts derived from rat left ventricle
and, more importantly, are alternatives to animal‐free studies.
Our study demonstrates that H9c2 cells are more relevant for
study on energy metabolism and mitochondrial function as of intact
heart.[39–41] Both H9c2 cells and human cardiomyocytes AC16
exhibit significant decreased mitochondrial function, cell viability,
and increased ROS production, whereas H9c2 cells are more
resistant to toxicants due to less mitochondrial content than AC16
cells.[42] Furthermore, human AC16 cardiac cells exposed to different
concentrations of high glucose at 24 hours have shown decreased
viability[43] similar to H9c2 cells in the present study. Although H9c2
cells and primary neonatal cardiomyocytes show similar responses in
viro,[44]the cell line aging process plays an important role in
cardiotoxicity studies in H9c2 cells.[45] Nevertheless, uncertainty
exists in determining the maximum number of passages required for
in vitro studies.
TABLE 1 Correlation between stress and mitochondrial parameters with cell survivability in hyperglycemic and trolox pretreated
hyperglycemic H9c2 cells
Cell viability ROS ATP MPT (Ca2+)i MDA PCC
Cell viability –
ROS −0.84**** –
ATP +0.78*** −0.82**** –
MPT −0.81**** +0.73*** −0.87**** –
(Ca2+)i −0.88**** +0.91**** −0.92**** +0.87**** –
MDA −0.83**** +0.88**** −0.83**** +0.71*** +0.85**** –
PCC −0.84**** +0.79*** −0.69*** +0.58** +0.78*** +0.91**** –
Abbreviations: ATP, adenosine triphosphate; (Ca2+)i, intracellular Ca
2+; MDA, malondialdehyde; MPT, mitochondrial permeability transition; PCC, protein
carbonyl content; ROS, reactive oxygen species. Data represented as Pearson's correlation with two‐tailed test between ROS, ATP, (Ca2+)i, MDA, and
PCC with cell survivability as “r” values (n = 3‐8).
****P < 0.0001.
***P < 0.001.
**P < 0.01.
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In summary, HG induces OS in cardiomyocytes. However, the
detrimental effect of HG is highly regulated. Lower concentrations of
glucose and shorter episodes maintained cell homeostasis and ATP
generation, whereas longer exposure could be harmful. Trolox exerted
cardioprotection against HG‐induced OS through prevention of ROS
accumulation, thereby ensuring optimal MPT and ATP levels. Hence,
Trolox can be used as a daily supplement with other drugs in terms of the
treatment and management of hyperglycemia‐induced cardiomyopathy.
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